Edition:
India

Ranbaxy Laboratories Ltd (RANB.NS)

RANB.NS on National Stock Exchange of India

859.80INR
1 Apr 2015
Change (% chg)

-- (--)
Prev Close
Rs859.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
Rs869.70
52-wk Low
Rs790.10

RANB.NS

Chart for RANB.NS

About

Ranbaxy Laboratories Limited (Ranbaxy) is a research-based international pharmaceutical company serving customers in over 150 countries. The Company develops, manufactures and markets generic, branded generic, value-added and over-the-counter (OTC) products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and... (more)

Overall

Beta: 0.23
Market Cap(Mil.): Rs365,745.31
Shares Outstanding(Mil.): 425.66
Dividend: --
Yield (%): --

Financials

  RANB.NS Industry Sector
P/E (TTM): -- 36.26 36.23
EPS (TTM): -19.13 -- --
ROI: -- 14.29 13.79
ROE: -- 15.13 14.74

EU court to rule on drugmaker Lundbeck's pay-for-delay deals

BRUSSELS, Sept 6 Europe's top court will rule on Thursday whether Danish drugmaker Lundbeck breached EU antitrust rules by paying smaller rivals to delay generic copies of its blockbuster citalopram anti-depressant from entering the market.

06 Sep 2016

BRIEF-Daiichi Sankyo announces outcome of arbitration proceeding with Ranbaxy

* Says Daiichi Sankyo received a final award in the arbitration that it filed with the International Court of Arbitration of the International Chamber of Commerce in November 2012 against the former shareholders Ranbaxy Laboratories Ltd. on May 3

06 May 2016

Japanese drugmaker Daiichi wins damages from former Ranbaxy owners

MUMBAI The former owners of Indian drugmaker Ranbaxy Laboratories have been ordered by an arbitration court to pay damages worth 25.63 billion rupees ($385 million) to Japan's Daiichi Sankyo Co Ltd, they said on Thursday.

05 May 2016

Earnings vs. Estimates